key: cord-0780072-nra74155
authors: Chen, Di; Zheng, Qiaoxia; Sun, Long; Ji, Mingming; Li, Yan; Deng, Hongyu; Zhang, Hong
title: ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress
date: 2021-10-11
journal: Dev Cell
DOI: 10.1016/j.devcel.2021.10.006
sha: 8528e19c5ab27cd2096f0c8a771aff9930237f00
doc_id: 780072
cord_uid: nra74155

Viral entry and egress are important determinants of virus infectivity and pathogenicity. β-Coronaviruses, including the COVID-19 virus SARS-CoV-2 and MHV, exploit the lysosomal exocytosis pathway for egress. Here we show that SARS-CoV-2 ORF3a, but not SARS-CoV ORF3a, promotes lysosomal exocytosis. SARS-CoV-2 ORF3a facilitates lysosomal targeting of the BORC-ARL8b complex, which mediates trafficking of lysosomes to the vicinity of the plasma membrane, and exocytosis-related SNARE proteins. The Ca2+ channel TRPML3 is required for SARS-CoV-2 ORF3a-mediatd lysosomal exocytosis. Expression of SARS-CoV-2 ORF3a greatly elevates extracellular viral release in cells infected with the coronavirus MHV-A59 which itself lacks ORF3a. In SARS-CoV-2 ORF3a, Ser171 and Trp193 are critical for promoting lysosomal exocytosis and blocking autophagy. When these residues are introduced into SARS-CoV ORF3a, it acquires the ability to promote lysosomal exocytosis and inhibit autophagy. Our results reveal a mechanism by which SARS-CoV-2 interacts with host factors to promote its extracellular egress.

β-Coronaviruses, including the severe acute respiratory syndrome (SARS) virus SARS-CoV, the COVID-19 virus SARS-CoV-2, and mouse hepatitis virus (MHV), are enveloped, positive-sense, single-stranded RNA viruses (Fung and Liu, 2019; Wu et al., 2020; Zhou et al., 2020) . SARS-CoV-2 and SARS-CoV enter host cells via binding of the viral surface spike (S) protein to its receptor ACE2 (angiotensin converting enzyme 2) on target cells (Hoffmann et al., 2020b; Zhou et al., 2020) . The S proteins of SARS-CoV and SARS-CoV-2, which display 87% protein similarity, are composed of S1 and S2 domains and are present as homotrimers (Wrapp et al., 2020) . Upon infection, the S protein is proteolytically activated by cellular proteases at the S1/S2 boundary to separate the S1 and S2 domains, and subsequently at the S2' site in the S2 domain (Hoffmann et al., 2020b) . S1 contains the receptor-binding domain (RBD) that mediates ACE2 recognition, whereas S2 triggers fusion of the viral and cellular membranes to enable the virus to enter the host cytoplasm (Hartenian et al., 2020) . The S protein can be cleaved by the cell surface protease J o u r n a l P r e -p r o o f TMPRSS2 to mediate viral/plasma membrane (PM) fusion, or by the lysosomal proteases cathepsin B and L (CTSB/L) when the virus is internalized via endocytosis to trigger viral/endosomal membrane fusion (Hartenian et al., 2020; Hoffmann et al., 2020b; Shang et al., 2020) . The extent to which each mechanism is employed depends on the differential expression of TMPRSS2 by different host cell types (Hoffmann et al., 2020b) . Compared to SARS-CoV RBD, SARS-CoV-2 RBD exhibits higher ACE2 binding affinity (Shang et al., 2020; Wrapp et al., 2020) . The SARS-CoV-2 S protein also contains multiple arginine residues at the S1/S2 cleavage site that can be recognized by the cellular protease furin, enabling pre-cleavage of S proteins during viral packaging in host cells (Hoffmann et al., 2020a; Shang et al., 2020) . The differential properties of the S protein contribute to the higher infectivity of SARS-CoV-2 compared with SARS-CoV (Hoffmann et al., 2020b; Peng et al., 2021; Shang et al., 2020) . Viral entry has been the focus for developing interventions, such as inhibiting ACE2 binding, inactivating host proteases or blocking membrane fusion (Hartenian et al., 2020; Peng et al., 2021) .

After the coronaviral RNA genome is released into the cytoplasm, it is translated into structural proteins and nonstructural proteins (NSPs). NSPs mediate the formation of double-membrane vesicles (DMVs), upon which the viral replication transcription complex (RTC) is anchored (Snijder et al., 2020) . The viral particles are assembled and budded into the lumen of the ER and the ER-Golgi intermediate compartment (ERGIC); they then traffic to the trans-Golgi network (TGN) and eventually reach the late endosomes/lysosomes (Fung and Liu, 2019; Ghosh et al., J o u r n a l P r e -p r o o f 2020). β-Coronaviruses exploit the ARL8b-dependent lysosomal exocytosis pathway for release into the extracellular environment (Ghosh et al., 2020) . During lysosomal exocytosis, the BORC-ARL8b complex drives anterograde transport of lysosomes from perinuclear regions to the vicinity of the PM (Pu et al., 2016) . Fusion of lysosomes with the PM is mediated by the SNARE complex composed of VAMP7, STX4 and SNAP23, and also requires an increase in the intracellular and/or localized Ca 2+ level (Rodriguez et al., 1997; Saftig and Klumperman, 2009; Tancini et al., 2020) . Very little is known about whether and how coronaviral proteins interact with host factors to control lysosomal exocytosis-mediated viral egress.

The autophagy-lysosome pathway acts as a surveillance system against pathogen invasion (Choi et al., 2018; Deretic et al., 2013; Levine et al., 2011; Wong and Sanyal, 2020) . Autophagy involves engulfment of a portion of unselected cytosolic materials or selected cargos (i.e. damaged organelles, protein aggregates and invading pathogens) in a double-membrane autophagosome (Lamb et al., 2013; Stolz et al., 2014) . The autophagosome fuses with endolysosomal vesicles such as late endosomes/lysosomes to form amphisomes, a process known as autophagosome maturation, which eventually leads to the formation of degradative autolysosomes (Zhao and Zhang, 2019; Zhao et al., 2021) . Viruses have developed mechanisms to evade autophagic destruction and even to hijack autophagic vacuoles (i.e. autophagosomes, amphisomes and nondegradative autolysosomes) for their own benefits, for example by promoting replication and release (Choi et al., 2018; Deretic et al., 2013; Wong and Sanyal, 2020; Zhao et al., 2021) . SARS-CoV-2 virus infection J o u r n a l P r e -p r o o f blocks autophagy at a step of autophagosome maturation, resulting in accumulation of autophagosomes and amphisomes (Miao et al., 2021) . Mechanistically, the late endosomal/lysosomal-localized viral ORF3a protein sequestrates the HOPS complex component VPS39, preventing it from interacting with the autophagosomal SNARE protein STX17. This blocks assembly of the trans-SNARE complex composed of STX17, SNAP29 and VAMP8 which drives fusion of autophagosomes and amphisomes with lysosomes (Miao et al., 2021) . ORF3a from the SARS virus SARS-CoV, however, fails to interact with VPS39 or block autophagosome maturation (Miao et al., 2021) .

Here we demonstrated that SARS-CoV-2 ORF3a, but not SARS-CoV ORF3a, promotes lysosomal exocytosis. SARS-CoV-2 ORF3a promotes the lysosomal targeting of the BORC-ARL8b complex and the exocytosis-related SNARE proteins VAMP7 and STX4, and also increases the cytosolic Ca 2+ level. Expression of SARS-CoV-2 ORF3a facilitates the egress of MHV-A59 virus, which lacks an ORF3a counterpart. We found that the serine at residue 171 and the tryptophan at residue 193 are essential for SARS-CoV-2 ORF3a to promote lysosomal exocytosis and inhibit autophagy. When these residues are introduced at the corresponding positions in SARS-CoV ORF3a, the mutated protein acquires the ability to promote lysosomal exocytosis and block autophagy. Our study provides mechanistic insights into how SARS-CoV-2 promotes lysosomal exocytosis and also shows that this process is differentially modulated by SARS-CoV-2 and SARS-CoV, which may contribute to the different levels of viral infectivity and pathogenicity.

J o u r n a l P r e -p r o o f

Lysosomal exocytosis results in plasma membrane (PM) localization of lysosomal membrane proteins and also the release of lysosomal contents into the extracellular environment (Luzio et al., 2007; Tancini et al., 2020) . To determine whether the late endosomal/lysosomal-localized SARS-CoV-2 ORF3a (referred to as ORF3a hereafter unless the viral origin is stated) is involved in lysosomal exocytosis, we examined the cell surface levels of two lysosomal membrane proteins, LAMP1 and LAMP2 in HeLa cells expressing ORF3a. PM was separated from soluble fractions by cell fractionation. Despite the expansion of the lysosome population (Miao et al., 2021) , the total levels of LAMP1 and LAMP2 were not evidently changed in ORF3a-expressing cells ( Figure 1A ). In the PM fraction derived from cells expressing ORF3a, LAMP1 and LAMP2 were more abundant and the proportion of LAMP1 and LAMP2 on the PM was higher compared to control cells ( Figure 1A ). Levels of mature cathepsin D (CTSD) and, to a lesser extent, cathepsin B (CTSB) were higher in the culture medium of ORF3a-expressing cells than control cells ( Figure 1B) . We next performed immunofluorescence staining to directly visualize cell surface-localized LAMP1. In this assay, live cells are incubated with a phycoerythrin (PE)-conjugated human LAMP1 antibody at 4 o C for 90 min, followed by fixation and detection (Rodriguez et al., 1997; Medina et al., 2011) . The cells are not J o u r n a l P r e -p r o o f permeabilized. Control cells contained low levels of cell surface-localized LAMP1 ( Figure 1C ), which results from constitutive fusion of lysosomes with the PM and/or trafficking of LAMP1 to the PM via the conventional secretory pathway (Braulke and Bonifacino, 2009 ). In cells expressing ORF3a, cell surface-localized LAMP1 was dramatically elevated (Figures 1D and 1E) . The signal was abolished if control cells or ORF3a-expressing cells were treated with Trypsin to remove surface proteins before incubating with the anti-LAMP1 antibody (Figures S1A-S1D). Cell surface-localized LAMP1 was clearly distinct from LysoTracker-stained intracellular lysosomes ( Figure S1E ). An anti-TOMM20 antibody detected abundant mitochondria in permeabilized cells, but not in live cells (Figures S1G and S1H). These results confirm that the live cell LAMP1 staining assay specifically detects cell surface-localized LAMP1, but not intracellular lysosomes, and thus the live cell staining assay was used in this study. Expressing ORF3a in other cell types such as COS7 cells also led to elevated levels of cell surface LAMP1 (Figures S1F, S1I and S1J). Brefeldin A (BFA) treatment, which blocks conventional secretory transport (Miller et al., 1992) , failed to suppress the elevated cell surface LAMP1 in ORF3a-expressing cells (Figures S1K-S1M). Together, these results provide evidence that expression of ORF3a promotes lysosomal exocytosis.

The BORC-ARL8b complex is essential for ORF3a-mediated lysosomal exocytosis During lysosomal exocytosis, lysosomes are transported anterogradely from the perinuclear region to the PM (Tancini et al., 2020) . The number and percentage of J o u r n a l P r e -p r o o f LAMP1-stained lysosomes close to the PM was greater in ORF3a-expressing cells ( Figures 1F, S1N and S1O). The late endosomal/lysosomal-associated multisubunit BORC complex recruits the small Arf-like Ras family GTPase ARL8b to promote ARL8b-dependent coupling to kinesin motors, which drives the movement of lysosomes toward the PM (Pu et al., 2016) . In control cells, the BORC component BORCS6 was largely diffuse in the cytosol and formed only a few puncta (Figure 2A ).

In ORF3a-expressing cells, BORCS6 formed a large number of puncta that colocalized or closely associated with ORF3a punctate structures ( Figures 2B and 2C ).

In GFP-TRAP assays, BORCS6, but not ARL8b, was evidently co-immunoprecipitated by ORF3a-GFP ( Figures 2G and 2N) . Depleting ARL8b or the BORC component BORCS3 caused juxtanuclear accumulation of lysosomes (Figures S1P-S1S). BORCS3 knockdown (KD) and ARL8b KD greatly reduced the PM accumulation of LAMP1 in control cells and ORF3a-expressing cells (Figures 2D-2F, and S1T-S1X). Thus, ORF3a facilitates lysosomal targeting of the BORC-ARL8b complex for exocytosis.

Lysosomal exocytosis is induced by an elevation in cytosolic Ca 2+ concentration (Rodriguez et al., 1997; Tancini et al., 2020) . Compared to control cells, the cytosolic intracellular free calcium concentration ([Ca 2+ ]i) was increased in ORF3a-expressing cells, rising from ~135 nM to ~220 nM ( Figures 2H and 2I ). We examined whether localized lysosomal Ca 2+ release was affected by ORF3a expression. To monitor the release of Ca 2+ from lysosomes, we constructed a lysosome-targeted genetically J o u r n a l P r e -p r o o f encoded Ca 2+ sensor in which GCaMP6f was linked to the C-terminal cytosolic tail of LAMP1 (LAMP1-GCaMP6f). In control cells, the majority of the LAMP1-GCaMP6f puncta exhibited very weak fluorescence and were largely distinct from LysoTracker-stained acidic lysosomes ( Figure S2A ). Only a few strongly fluorescent LAMP1-GCaMP6f puncta were detected ( Figure 2J ). However, in ORF3a-expressing cells, the number of puncta with strong LAMP1-GCaMP6f signal was dramatically increased ( Figures 2K and 2L ). LAMP1-GCaMP6f was largely colocalized with ORF3a-labeled late endosomes/lysosomes and also with puncta that were weakly stained by LysoTracker ( Figures 2K and S2B ). HBSS-induced starvation has been shown to trigger the release of Ca 2+ from lysosomes (Medina et al., 2015) . Compared to control cells, the amplitude of lysosomal Ca 2+ released in ORF3a-expressing cells was much larger than in control cells ( Figures 2M and 2O ).

SARS-CoV-2 ORF3a has been shown to form Ca 2+ -permeable non-selective cation channels (Kern et al., 2021) . Mutating residues located at the top of the channel cavity, Q57E or S58L Q116L, reduces Ca 2+ permeability (Kern et al., 2021) . We found that expression of ORF3a(Q57E) or ORF3a(S58L Q116L), like wild-type (Figures S2N-S2R ). We found that the cytosolic Ca 2+ concentration was still slightly increased in cells expressing J o u r n a l P r e -p r o o f ORF3a(Q57E) or ORF3a(S58L Q116L) (Figures S2S), which is consistent with the notion that these mutants attenuate, but do not abolish, the Ca 2+ permeability (Kern et al., 2021) . Therefore, lysosomal-localized Ca 2+ release in ORF3a(Q57E)-or ORF3a(S58L Q116L)-expressing cells is likely mediated by the partial Ca 2+ permeability retained by these ORF3a mutants.

We next examined whether the TRPML channels are involved in ORF3a-mediated lysosomal exocytosis. In control cells, the puncta strongly labeled by the lysosomal Ca 2+ channel TRPML1 were localized close to the PM ( Figure S2T ).

In ORF3a-expressing cells, many more lysosomes showed strong TRPML1 signal and were largely colocalized with ORF3a punctate structures ( Figures S2U and S2V ).

ORF3a-GFP co-immunoprecipitated TRPML1 in GFP-Trap assays ( Figure 2N ), suggesting that ORF3a may facilitate lysosomal targeting of TRPML1. The PM-localized LAMP1 in ORF3a-expressing cells, however, was not evidently affected in TRPML1 knockout cells (Figures 2P and S2W) . TRPML3 has been shown to promote expulsion of bacterium-containing neutralized lysosomes (Miao et al., 2015) . Simultaneously depleting TRPML3 in ORF3a-expressing cells resulted in localization of LAMP1-GCaMP6f puncta in the proximity of the PM, but did not change the number of puncta ( Figures S2X-S2A1 ). Knocking down TRPML3 reduced the level of PM-localized LAMP1 in control cells and also dramatically inhibited the enhanced lysosomal exocytosis in ORF3a-expressing cells ( Figures 2P, 2Q , S2B1 and S2C1). ORF3a-GFP also interacted with TRPML3 in GFP-Trap assays ( Figure 2N ). Therefore, the increased lysosomal Ca 2+ release mediated by ORF3a is not sufficient J o u r n a l P r e -p r o o f to drive fusion of lysosomes with the PM. TRPML3 is required for the ORF3a-induced enhancement of lysosomal exocytosis.

During lysosomal exocytosis, fusion of lysosomes with the PM is mediated by the assembly of the trans-SNARE complex composed of VAMP7, STX4 and SNAP23 (Saftig and Klumperman, 2009; Tancini et al., 2020) . In control cells, VAMP7-GFP weakly labeled the PM and formed puncta that only partially colocalized with LAMP1-labeled late endosomes/lysosomes ( Figures 3A and S3A ).

STX4-GFP was also weakly detected on the PM and formed a few puncta ( Figure 3D ), while SNAP23 was largely localized in the cytosol and the PM ( Figure S3E ). In ORF3a-expressing cells, the numbers of VAMP7 puncta and STX4 puncta were greatly increased, and they extensively colocalized with ORF3a punctate structures KD did not evidently affect the cell surface-localized LAMP1 ( Figures 3I, S3N and S3O), which may be because its function is substituted by other PM-localized SNARE proteins such as SNAP25 as reported (Sørensen et al., 2003) . In ORF3a-expressing cells with simultaneous knockdown of STX4, the yellow puncta formed by the RFP-GFP-LC3 reporter (unacidified autophagic structures) still accumulated ( Figures S3P-S3R ), which indicates that the defective autophagosome maturation is not due to reduced availability of intracellular lysosomes in ORF3-expressing cells. Thus, VAMP7 and STX4 are involved in ORF3a-mediated lysosomal exocytosis.

The expression pattern of Flag-STX1A, VAMP2-GFP, SNAP25-GFP, GFP-STX18, and VAMP4-GFP remained largely unchanged in ORF3a-expressing cells ( Figures S4A-S4K ). STX6 is localized in the TGN and forms a few cytosolic punctate structures in control cells (Laufman et al., 2011) . In ORF3a-expressing cells, STX6 formed far more puncta ( Figures S4L-S4N ). However, no interaction was detected between STX6 and ORF3a in GFP-Trap assays ( Figure 3J ). STX6 KD had no effect on the number of VAMP7 puncta, or on the elevated level of PM-localized LAMP1 in ORF3a-expressing cells (Figures 3H, 3I and S4O-S4Q).

Expression of ORF3a results in sequestration of the HOPS component VPS39 on late endosomes/lysosomes (Miao et al., 2021) . We determined whether VPS39 contributes to the enhanced lysosomal exocytosis in ORF3a-expressing cells. The TFEB has been shown to be predominantly localized in the nucleus in ORF3a-expressing cells via an unknown mechanism (Figures S4W and S4X) (Miao et al., 2021) . TFEB overexpression promotes lysosomal exocytosis (Medina et al., 2011) .

Unlike in ORF3a-expressing cells, the formation of VPS39-GFP, BORCS6-GFP, STX4-GFP and VAMP7-GFP puncta was not evidently changed in TFEB-overexpressing cells ( Figures S5A-S5I ). As shown below, a mutant ORF3a causes TFEB nuclear localization but does not enhance lysosomal exocytosis. The nuclear-localized TFEB in ORF3a-expressing cells is not functional, as the mRNA levels of the majority of TFEB targets remain unchanged (Miao et al., 2021) . Taken together, our results indicate that ORF3a promotes lysosomal exocytosis independent of nuclear-localized TFEB.

We next examined whether SARS-CoV-2 infection also elevates lysosomal exocytosis. In SARS-CoV-2 virus-infected Vero E6 cells or in HeLa cells expressing J o u r n a l P r e -p r o o f ACE2, staining with the PE-conjugated anti-LAMP1 antibody showed dramatically elevated cell surface LAMP1 ( Figures 5A-5E ). In control cells, VAMP7 and STX4 were largely diffuse and formed a very few punctate structures ( Figures 5F and 5H ).

However, a large number of VAMP7 and STX4 puncta were detected in SARS-CoV-2-infected cells ( Figures 5G, 5I and 5J). The numbers of VAMP7 and STX4 puncta were also dramatically increased in SARS-CoV-2-infected Vero E6 cells ( Figures 5J-5N ). Therefore, as in ORF3a-expressing cells, SARS-CoV-2 virus infection increases the recruitment of STX4 and VAMP7 and also promotes lysosomal exocytosis.

The coronavirus MHV-A59 also exploits lysosomal exocytosis for egress (Ghosh et al., 2020) . MHV-A59 does not contain an ORF3a homolog. We investigated ORF3a(S171E)-GFP also failed to promote the formation of VAMP7-GFP puncta and STX4-GFP puncta ( Figures 6J, and S5E1 and S5H1). Compared to ORF3a-GFP, ORF3a(S171E)-GFP formed fewer punctate structures ( Figure S5B1 ). The elevated PM-localized LAMP1 was also abolished in ORF3a(S171E)-expressing cells ( Figures   6H and 6I ). The S171E mutation also abolished the ability of ORF3a to increase cytosolic free Ca 2+ , HBSS-induced lysosomal Ca 2+ release, and the number of blocks autophagy. Therefore, mutating E171S and R193W is sufficient to endow SARS-CoV ORF3a with the ability to promote lysosomal exocytosis and block autophagy.

During the cycle of β-coronavirus infection including SARS-CoV-2 and MHV, newly assembled viral particles traffic to late endosomes/lysosomes and then exploit the lysosomal exocytosis pathway for release (Ghosh et al., 2020) . Lysosomal exocytosis is enhanced by β-coronavirus infection (Ghosh et al., 2020) , but the underlying mechanism remains largely unknown. Here we revealed that SARS-CoV-2

ORF3a promotes multiple steps involved in lysosomal exocytosis ( Figure 7N ). In

ORF3a-expressing cells, targeting of the BORC-ARL8b complex to late endosomes/lysosomes is greatly enhanced, suggesting that anterograde lysosome J o u r n a l P r e -p r o o f transport is facilitated. VAMP7 and STX4 are also targeted to ORF3a-localized late endosomes/lysosomes at an enhanced level by ORF3a. Depleting BORC, ARL8b, VAMP7 or STX4 abolishes the enhanced lysosomal exocytosis in ORF3a-expressing cells.

Fusion of lysosomes with the PM requires an elevated cytosolic Ca 2+ level, which could result from extracellular Ca 2+ influx or localized lysosomal Ca 2+ release (Rodriguez et al., 1997; Saftig and Klumperman, 2009) . TRPML1 has been shown to mediate the localized lysosomal Ca 2+ release that is needed for lysosomal exocytosis in response to TFEB expression and at the phagocytic cup during large particle uptake (Medina et al., 2011; Samie et al., 2013) . TRPML3 senses lysosome neutralization and triggers Ca 2+ efflux to stimulate lysosomal exocytosis such as in expulsion of lysosome-encased uropathogenic E. coli (Miao et al., 2015; Tancini et al., 2020) .

β-Coronavirus infection results in deacidification of lysosomes (Ghosh et al., 2020) , which may result from loading with too many viral particles, and/or perturbations in proton pump or ion channel activity by viral proteins. In ORF3a-expressing cells. the LysoTracker fluorescence intensity is weaker in a subpopulation of lysosomes (Ghosh et al., 2020; Miao et al., 2021) . We showed here that ORF3a expression elevates cytosolic Ca 2+ concentration and localized lysosomal Ca 2+ release as shown by an increase in the number of LAMP1-GCaMP6f puncta. ORF3a itself is a Ca 2+ -permeable channel, whose activity is not affected by pH (Kern et al., 2021) . In

ORF3a-expressing cells with simultaneous knockdown of TRPML3, a large number of LAMP1-GCaMP6f puncta still accumulate in the vicinity of the PM, but the J o u r n a l P r e -p r o o f enhanced lysosomal exocytosis is inhibited. This suggests that TRPML3 is not responsible for localized lysosomal Ca 2+ release but is required for triggering the fusion of lysosomes with the PM. TRPML3 is widely distributed, including in the PM, the ER and intracellular compartments (e.g. lysosomes). Thus, TRPML3 can mobilize multiple Ca 2+ stores to promote lysosomal exocytosis (Kim et al., 2009) . In ORF3a-expressing cells, LAMP1-GCaMP6f puncta are weakly stained by LysoTracker, which suggests that ORF3a-induced lysosome neutralization may activate TRPML3. The lysosomal-localized synaptotagmin VII (SYT7) has also been implicated in promoting fusion of lysosomes with the PM (Tancini et al., 2020) .

SYT7 labels more puncta in ORF3a-expressing cells and in SARS-CoV-2 infected cells ( Figures S7J-S7N) . However, SYT7 KD has no evident effect on enhanced lysosomal exocytosis in ORF3a-expressing cells ( Figures S7O-S7Q) , suggesting that other Syt proteins or Ca 2+ sensors may be involved in this process. CQ treatment, which strongly deacidifies lysosomes so that they have no LysoTracker staining signal, facilitates lysosomal exocytosis, but to a lesser extent than ORF3a expression ( Figures S7R-S7W) . Thus, SARS-CoV-2 ORF3a exploits a mechanism that is at least partly independent of lysosomal alkalinization to enhance lysosomal exocytosis.

Lysosomes/late endosomes exhibit heterogeneity in their size, morphology and resident enzymes. ORF3a mainly labels late endosomes/lysosomes positive for RAB7 and LAMP1; it only labels a subset of LAMP2-positive lysosomes (Miao et al., 2021) .

In ORF3a-expressing cells, a certain percentage of accumulated amphisomes are positive for both LC3 and RAB7/LAMP1 (Miao et al., 2021) . Virion particles are J o u r n a l P r e -p r o o f detected in amphisome-like structures in SARS-CoV-2-infected cells (Miao et al., 2021) . TFEB has been shown to induce exocytosis of the arrested autolysosomes in Pompe disease muscle cells (Spampanato et al., 2013) . Exocytosis of amphisomes may also be enhanced by ORF3a. VPS39, which is sequestrated on late endosomes/lysosomes by ORF3a (Miao et al., 2021) , contributes to recruitment and/or stabilization of BORC, VAMP7 and STX4 on lysosomes and also to enhanced lysosomal exocytosis in ORF3a-expressing cells. Thus, sequestration of VPS39 on late endosomes/lysosomes by ORF3a has the dual ability to block autophagosome maturation and promote lysosomal exocytosis. Although the physiological relevance of ORF3a in SARS-CoV-2 egress has yet to be determined, expression of ORF3a increases the viral titer of supernatants from MHV-A59-infected cells, which supports the notion that ORF3a has an important function in promoting lysosomal exocytosis-mediated viral egress.

Unravelling the differential functions of SARS-CoV-2 and SARS-CoV proteins is crucial for us to understand the mechanisms which endow SARS-CoV-2 with much higher infectivity and pathogenicity than SARS-CoV. Previous studies demonstrated that multiple differential properties of the S protein enable SARS-CoV-2 to enter more efficiently into host cells than SARS-CoV (Shang et al., 2020; Wrapp et al., 2020) . Compared to the SARS-CoV S protein, SARS-CoV-2 S protein possesses a multibasic domain at the S1/S2 cleavage site that allows pre-cleavage by furin during J o u r n a l P r e -p r o o f viral packaging in host cells (Hoffmann et al., 2020a; Shang et al., 2020) , its RBD exhibits higher ACE2 binding affinity (Wrapp et al., 2020) , and it adopts conformations less susceptible to immune surveillance (Shang et al., 2020) .

ORF3a is an accessory protein present only in a subset of coronaviruses. ORF3a of SARS-CoV and SARS-CoV-2 forms a homotetrameric complex and possesses non-selective cation channel activity (Castano- Rodriguez et al., 2018; Kern et al., 2020; Lu et al., 2006) . SARS-CoV ORF3a protein localizes to the PM and Golgi apparatus and also forms a few cytoplasmic punctate structures (Castano- Rodriguez et al., 2018; Lu et al., 2006; Minakshi and Padhan, 2014) . SARS-CoV ORF3a regulates various cellular responses, including apoptosis (Tan et al., 2006) , activation of NF-B and NLRP3 inflammasome (Siu et al., 2019) , and production of inflammatory chemokines (Kanzawa et al., 2006) . Deletion of ORF3a has no effect on the extracellular release of SARS-CoV from cultured cells (Freundt et al., 2010) . In mouse models of SARS-CoV infection, genomic deletion of ORF3a reduces viral titer and virulence (Castano- Rodriguez et al., 2018) . SARS-CoV-2 ORF3a is localized on late endosomes/lysosomes as well as on the PM (Miao et al., 2021) . SARS-CoV-2

ORF3a has been shown to contribute to viral pathogenesis in the mouse model of SARS-CoV-2 infection (Silvas et al., 2021) . Compared to the parental virus, infection with virus with a deletion of ORF3a results in lower viral titers, faster recovery of lung pathology, and reduced morbidity (Silvas et al., 2021) . Our studies revealed that SARS-CoV-2 ORF3a, but not SARS-CoV ORF3a, sequestrates VPS39 on late endosomes/lysosomes, blocks autophagosome maturation (Miao et al., 2021) , and 

There are several limitations to our study: An elevation in cytosolic Ca 2+ concentration and/or localized lysosomal Ca 2+ release has been previously shown to promote lysosomal exocytosis (Rodriguez et al., 1997; Tancini et al., 2020) . The mechanism underlying the additional requirement for TRPML3 in the ORF3a-induced enhancement of lysosomal exocytosis has not been investigated. In addition, the J o u r n a l P r e -p r o o f location (e.g. the PM, the ER or lysosomes) where TRPML3 acts to mobilize Ca 2+ should be explored in the future. Sequestration of VPS39 on late endosomes/lysosomes is required for the enhanced lysosomal exocytosis in ORF3a-expressing cells. VPS39 is a subunit of the HOPS complex and also forms a subcomplex with VPS11 or VPS41. The interactions of VPS39 with different subunits of the HOPS complex is differentially affected by ORF3a expression (Miao et al., 2021) . Our study does not determine whether VPS39 acts in a functional HOPS complex or in a subcomplex to regulate lysosomal exocytosis in ORF3a-expressing cells. We found that ORF3a overexpression facilitates MHV-A59 egress. Future studies will be required to investigate the role of ORF3a in lysosomal exocytosis-mediated egress of SARS-CoV-2. all mammalian tissue culture experiments. L.S. conducted the MHV-A59 experiments.

The authors declare no competing interests.

Supplemental Information includes one table and seven figures. 

ORF3a-mCherry (ORF3a) after inducing lysosomal Ca 2+ release by HBSS. Figure 2D . (n=33, 23, 21, 28, 29, 23, 16 for bars from left to right). *, P <0.05; ***, P <0.001; n.s., no significant difference. The data for Control and ORF3a-expressing cells are the same as those in Figure 1E .

(J) Quantification of the number of STX4-GFP and VAMP7-GFP puncta in cells expressing mCherry (Control), ORF3a-mCherry, ORF3a(S171E)-mCherry and SARS-CoV ORF3a-mCherry. Data are shown as mean ± S.E.M. (n=16, 30, 24, 19, 14, 31, 22, 19 for bars from left to right). ***, P <0.001. The data for ORF3a-expressing cells are the same as those in Figure 3C . 

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hong Zhang (hongzhang@ibp.ac.cn).

Plasmids and other reagents generated in this study will be available upon request from the Lead Contact with a completed Materials Transfer Agreement.

• All data reported in this paper are available from the lead contact upon request.

• This paper does not report original code.

• Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

HeLa cells and COS7 cells were obtained from ATCC. Mouse fibroblast 17Cl-1 Table 1 .

HeLa cells were cultured on coverslips in 24-well cell culture plates and transfected with human ACE2 and indicated plasmids. 12 h later, cells were infected with 1 10 5 TCID50/ml SARS-CoV-2 virus (hCoV-19/China/CAS-B001/2020, GISAID No. EPI_ISL_514256-7) for 1 hour. After 3 washes with PBS, cells were incubated in culture medium for 24 h at 37 o C with 5% CO2, fixed with 4% PFA for 24 h at room temperature, and then subjected to normal procedures for immunostaining analysis. All of the experiments with SARS-CoV-2 virus were performed inside biosafety cabinets in the biosafety level 3 facility at the Institute of Microbiology, Chinese Academy of Sciences. SARS-CoV-2 virus was propagated in Vero E6 cells and the virus titer was determined by cytopathic efficiency (CPE) assays. 

Ratiometric single cell [Ca 2+ ]i imaging was performed on an IX-81 microscope (Olympus)-based system as described previously (Zheng et al., 2013; Zhou et al., 2014) . HeLa cells were incubated in DMEM containing 2 μM Fura-2 AM at 37 °C for 30 minutes. Transfected cells were identified by the presence of fused or co-expressed eGFP. Semrock filters (BrightLine single-band multi-exciter filter set, optimized for Fura-2) were used to minimize contamination of Fura-2 fluorescence by bleed-through of eGFP fluorescence. Data were acquired with Metafluor software (Universal Imaging) and analyzed with Origin2020b software (OriginLab) and are expressed as means ± S.E.M..

Time-lapse imaging was performed on an inverted confocal microscope Zeiss LSM880 microscope with a 63×, 1.3 NA oil-immersion objective. The axial resolution was set to 1.0 μm. Ex=488 nm, Em=490~660 nm. Images were acquired at 512×512 pixels, 1 s/frame, 30 frames/min. HeLa cells were transfected with the lysosome-targeted genetically encoded Ca 2+ sensor LAMP1-GCaMP6f and plated in Mattek glass-bottomed dishes 24 h before imaging and measurement. After 24 h, cells were firstly placed in 1 ml of complete DMEM medium for 1 minute to obtain resting F0. Then the medium was carefully changed from DMEM to HBSS, and imaging was continued for 10 minutes to obtain starvation-induced lysosome Ca 2+ release (Medina et al., 2015) .

The time-lapse LSM files generated from the Zeiss LSM 880 were analyzed using custom-developed programs written in interactive data language (IDL Research Systems). Cell motion artefacts and background fluorescence changes were corrected by image processing. For parametric quantification, we measured the amplitude (ΔF/F0, dimensionless) of each cell (Lu et al., 2019) .

Cells were seeded on Mattek glass-bottomed dishes and cultured with DMEM medium. For Ca 2+ measurement, the cells were loaded with 5 μM Fluo4-AM 

For immunostaining, cells were seeded on coverslips and cultured in 24-well cell culture plates. After transfection with the indicated plasmids, cells were washed 3 times with PBS and fixed with 4% paraformaldehyde for 20 min. Then, cells were permeabilized with 100 μg/ml digitonin (D141, Sigma) for 10 min at room temperature with gentle shaking and blocked with 5% goat serum for 60 min. After incubation with the indicated primary antibodies (diluted in 5% goat serum) for 1.5 h at room temperature or overnight at 4 o C, cells were washed with PBS and stained with fluorescently-labeled secondary antibodies for 1 h at room temperature. After 3 washes with PBS, the coverslips were mounted with DAPI in 50% glycerol. Confocal images were acquired by a Zeiss LSM 880 Meta plus Zeiss Axiovert zoom. The J o u r n a l P r e -p r o o f following antibodies were used in this study: LC3 antibody (M152-3, MBL), p62 antibody (PM045, MBL), LAMP1 antibody (553792, BD Biosciences), Flag antibody (F1804, Sigma), Flag antibody (14793S, Cell Signaling Technology).

Cells were cultured on coverslips in 24-well cell culture plates. For live-cell staining, cells were incubated with PE-conjugated human LAMP1 antibody (328608, BioLegend) in culture medium at 4 o C for 90 min according to the manufacturer's instructions. After gently washed 3 times by PBS, cells were immediately fixed with 4% paraformaldehyde for 20 min, then stained with fluorescently-labeled secondary antibodies for 2 h at room temperature to amplify the signal. For 17Cl-1 cells, cells were stained with a mouse LAMP1 antibody (560948, BD Biosciences) for 90 min in culture medium at 4 o C. Cells were fixed and then stained with fluorescently-labeled secondary antibodies for 2 h at room temperature.

For trypsin treatment, cells were transfected with indicated plasmids for 24 h.

After 3 washes by PBS, cells were treated by trypsin (25200072, Gibco) for 10 min, plated on coverslips coated with 1% poly-lysine for 10 min, then subjected to the PE-anti-LAMP1 staining protocol for live cells as described above.

For LysoTracker Green staining, cells were incubated with LysoTracker Green (L7526, Life Technologies) at 37℃ for 30 min according to the manufacturer's instructions. The cells were then used for live cell staining as described above.

After the indicated operations, cells were washed 3 times by PBS and lysed with J o u r n a l P r e -p r o o f lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100) supplemented with protease inhibitor cocktail for 15 min on ice. After centrifuging (13,000 rpm) for 15 min at 4 o C, cell lysates were mixed with SDS loading buffer and boiled for 10 min. For analysis of CTSB and CTSD in culture medium, equal numbers of HeLa cells were seeded into 24-well cell culture plates with an equal volume of culture medium and transfected by the indicated plasmids. After 24 h culturing at 37 o C, culture medium was mixed with SDS loading buffer and boiled for 10 min.

Samples were subjected to SDS-PAGE electrophoresis and transferred onto 0.45 μm PVDF membranes. Signals on PVDF membranes were detected using the indicated primary and secondary antibodies. Total proteins in culture medium were detected by Ponceau S (P0022, Beyotime) staining. Antibodies used in immunoblotting assays are listed in Key Resources Table.

After transfection with the indicated plasmids and washing with PBS buffer, HeLa cells were lysed in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and protease inhibitor cocktail) on ice for 20 min and centrifuged at 13,000 rpm for 15 min at 4 o C. The supernatant was immunoprecipitated by GFP-Trap agarose beads (GNA-20-400, V-nanoab) for 1 h at 4 o C with rotation. After 5 washes with lysis buffer, agarose beads were collected by centrifugation (3000 rpm, 1 min) and boiled with SDS loading buffer for 10 min.

Samples were subjected to immunoblotting assays.

J o u r n a l P r e -p r o o f Plasma membranes were isolated by using a cell fractionation kit (SM-005, Invent Biotechnologies) according to the manufacturer's protocol. The purity of the different fractions was estimated by immunoblotting analysis of diagnostic proteins.

Total RNA was isolated using Trizol reagent (15596018, Life Technologies).

cDNA libraries were constructed with a RevertAid First Strand cDNA Synthesis Kit (K1622, Thermo Scientific) according to manufacturer's instructions. RT-PCR was performed using specific primers and UltraSYBR Mixture (High ROX) (CW2602M, CWBIO) on a QuantStudio 7 Flex (Applied Biosystems) instrument. mRNA levels were normalized by GAPDH mRNA levels. The RT primers are listed in supplemental Table 1 .

The sgRNA targeting human TRPML1 (5'-TGCCAGCGGTACTACCACCG-3') was designed using the CRISPR design tool (http://chopchop.cbu.uib.no/) and cloned into a vector (pX458) containing human codon-optimized Cas9, RNA components and EGFP (Addgene, 48138). The plasmid was transfected into HeLa cells using Lipofectamine 2000 (11668019, Invitrogen) for 24 h. Then GFP-positive cells were single-cell sorted into 96-well plates.

DNA was extracted from single cell clones and sequenced to analyze CRISPR targeting. Sequences were analyzed by CRISPR-ID software (Dehairs et al., 2016) and decoded manually. The following primers were used for sequencing: Forward: 5'-GATGACACCTTCGCAGCCTA-3' J o u r n a l P r e -p r o o f Reverse: 5'-AGACAAGGTCTTCCTACGTGG-3'.

All of the experiments were repeated at least 3 times on separate days with separate, independent populations. Graph plots and P-values were generated using GraphPad Prism 5 software. Density of immunoblot bands was quantified using Image J software (NIH Image). Image J was used to quantify the immunofluorescence intensity of the images. Statistical comparisons were made using the unpaired Student's t test and are shown as mean ± S.E.M.. *, P<0.05; **, P<0.01; ***, P<0.001 and n.s. represents "no significant difference". Sample size (with n representing the number of cells) and statistical significance (P value) are reported in the figure legends. Table S1 . List of oligonucleotides used in this study (related to STAR METHODS: Key Resources Table) J o u r n a l P r e -p r o o f

Sorting of lysosomal proteins

Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis

Autophagy during viral infection -a double-edged sword

CRISP-ID: decoding CRISPR mediated indels by Sanger sequencing

Autophagy in infection, inflammation and immunity

The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death

Human Coronavirus: Host-Pathogen Interaction

beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

The molecular virology of coronaviruses

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation

Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs

The Ca(2+) channel TRPML3 regulates membrane trafficking and autophagy

Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

The autophagosome: origins unknown, biogenesis complex

The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport

Autophagy in immunity and inflammation

TMCO1-mediated Ca2+ leak underlies osteoblast functions via CaMKII signaling

Imaging elemental events of store-operated Ca2+ entry in invading cancer cells with plasmalemmal targeted sensors

Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release

Lysosomes: fusion and function

Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB

Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance

ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation

A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion

Post-Golgi membrane traffic: brefeldin A inhibits export from distal Golgi compartments to the cell surface but not recycling

The YXXØ set motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport

The Role of Atg Proteins in Autophagosome Formation

Cell entry by SARS-CoV-2

Mechanisms and functions of lysosome positioning

Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells

Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function

A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis

Cell entry mechanisms of SARS-CoV-2

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice

Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC

A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis

Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23

Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease

Cargo recognition and trafficking in selective autophagy

Central role of IP(3)R2-mediated Ca 2+ oscillation in self-renewal of liver cancer stem cells elucidated by high-signal ER sensor

Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus

Lysosomal Exocytosis: The Extracellular Role of an Intracellular Organelle

Manipulation of autophagy by (+) RNA viruses

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

A new coronavirus associated with human respiratory disease in China

Machinery, regulation and pathophysiological implications of autophagosome maturation

Autophagosome maturation: An epic journey from the ER to lysosomes

Differential Roles of the C and N Termini of Orai1 Protein in Interacting with Stromal Interaction Molecule 1 (STIM1) for Ca 2+ Release-activated Ca2+ (CRAC) Channel Activation

Stromal Interaction Molecule 1 (STIM1) and Orai1 Mediate Histamine-evoked Calcium Entry and Nuclear Factor of Activated T-cells (NFAT) Signaling in Human Umbilical Vein Endothelial Cells

A pneumonia outbreak associated with a new coronavirus of probable bat origin

We are grateful to Dr. Isabel Hanson for editing work. We thank Dr. Yuhai Bi